Patent · US Active

Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides

US9168224B2 · kind B2 · utility

3Cited by

5References

4Claims

0Family size

Assignee

Meda Pharma S.p.A. · LU

Inventors

Meir Eini · Nes Ziona, IL
Doron Friedman · Karmei Yosef, IL
Stefan Hirsch · Neustadt, DE
Sabine Meyenburg · Inzlingen, DE
Nabila Sekkat · Basel, CH
Dov Tamarkin · Nes Ziona, IL

Key dates

Filing date	Apr 7, 2005
Grant date	Oct 27, 2015
Priority date	—
Expiry date	Nov 11, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/26
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical foam compositions substantially free of ethanol and comprising pimecrolimus in a carrier vehicle comprising a mixture of oily solvents amounting to at least 40% of the total weight of the composition and consisting of: They are indicated for use in the treatment of various skin, nail and mucosal diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.